Status History
2026-08-01
OPEN → INELIGIBLE
· The programme is a curated editorial list of biopharma companies, not an open application. It requires companies headquartered in Europe, founded in 2021 or later, and having raised funding in 2024 or later. The applicant is an individual researcher, not a company.